Back to Rafferty Asset Management, LLC Rafferty Asset Management, LLC

BBIOBBIO
27 quarters

Position history for Rafferty Asset Management, LLCRafferty Asset Management, LLC's holdings in BRIDGEBIO PHARMA INC

Rafferty Asset Management, LLC holds 40,953 shares of BBIO (BRIDGEBIO PHARMA INC), worth $3.1M as of 2026-Q2. The position was decreased (-35.2% shares). BBIO represents 0.0% of Rafferty Asset Management, LLC's portfolio.

Current Value

$3.1M

Current Shares

40,953

Total Value Change

+$2.4M

Total Shares Change

+21,705

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
40,953
-35.2%
$3.1M0.0%$74.48
0
2026-Q1
Decreased
63,180
-21.0%
$4.7M0.0%$74.26
0
2025-Q4
Decreased
80,018
-47.4%
$6.1M0.0%$76.49
0
2025-Q3
Decreased
151,990
-22.8%
$7.9M0.0%$51.94
0
2025-Q2
Decreased
196,782
-2.6%
$8.5M0.0%$43.18
0
2025-Q1
Decreased
202,128
-19.2%
$7M0.0%$34.57
0
2024-Q4
Increased
250,242
+2.8%
$6.9M0.0%$27.44
28
2024-Q3
Decreased
243,331
-10.4%
$6.2M0.0%$25.46
0
2024-Q2
Decreased
271,607
-14.2%
$6.9M0.0%$25.33
0
2024-Q1
Increased
316,442
+14.6%
$9.8M0.0%$30.92
32
2023-Q4
Decreased
276,073
-11.9%
$11.1M0.0%$40.37
0
2023-Q3
Decreased
313,382
-39.6%
$8.3M0.0%$26.37
0
2023-Q2
Increased
519,246
+52.1%
$8.9M0.1%$17.20
38
2023-Q1
Decreased
341,280
-52.5%
$5.7M0.0%$16.58
0
2022-Q4
Increased
719,269
+21.8%
$5.5M0.0%$7.62
32
2022-Q3
Increased
590,740
+30.4%
$5.9M0.1%$9.94
34
2022-Q2
Decreased
453,080
-27.3%
$4.1M0.0%$9.08
0
2022-Q1
Increased
623,202
+327.7%
$6.3M0.0%$10.15
44
2021-Q4
Increased
145,704
+135.5%
$2.4M0.0%$16.68
42
2021-Q3
Increased
61,881
+51.7%
$2.9M0.0%$46.87
37
2021-Q2
Decreased
40,803
-13.1%
$2.5M0.0%$60.96
0
2021-Q1
Increased
46,950
+209.0%
$2.9M0.0%$61.60
42
2020-Q4
Decreased
15,196
-65.7%
$1.1M0.0%$71.11
0
2020-Q3
Increased
44,255
+32.9%
$1.7M0.0%$37.52
33
2020-Q2
New
33,309
-
$1.1M0.0%$32.61
35
2020-Q1
Exited
0
-100.0%
$00.0%$29.00
0
2019-Q4
New
19,248
-
$675,0000.0%$35.05
34

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used